BeStock  
Stocks › Medical Devices › BBNX

Beta Bionics BBNX

US equityMarket cap rank #3400Medical Devices
$18.08 −$0.55 (-2.95%)
Pre-market · Oct 8, 9:10 am ET · After hours $18.08 0.00%
Open$18.91
Prev close$18.63
Day range$17.93 – $19.11
Volume1.53M
Market cap$813.41M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership101.3%-21.98 pts vs. prior quarter
Institutions holding173+1 vs. prior quarter
Insider trades (recent)20 buys / 30 sellsNet selling
Short interest23.60% of floatDays to cover 9.9 · as of 15 Sep 2026
Short-sale volume share23.4%5-day average of daily volume

Short-sale volume as % of daily volume

7%18%28%39%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$1.61M (10 inflow days, 10 outflow days).

Net flow by order size, last 20 sessions

−$1.7MSuper+$87.7KBig−$1.3MMid−$663.8KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 41.6% of shares outstanding.

Largest holders

  • Eventide Asset Management, LLC11.88%
  • Soleus Capital Management, L.P.8.35%
  • Morgan Stanley8.02%
  • Sands Capital Alternatives, LLC7.04%
  • BlackRock6.35%
  • Divisadero Street Capital Management, LP5.84%
  • Soleus Capital LLC5.12%
  • Point72 Asset Management, L.P.4.28%

By investor type

  • Hedge Fund37.89%
  • Mutual Fund35.03%
  • VC/PE Fund16.25%
  • Public Company10.40%
  • Individual/Insider4.40%
  • Government Pension Fund0.83%
  • Sovereign Wealth Fund0.37%
  • Private Company0.30%

Reported short interest has risen from 15.30% to 23.60% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Dimensional Fund Advisors Mutual Fund 2026/Q3 +106,001 0.2%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +86,314 0.2%
Divisadero Street Capital Management, LP Hedge Fund 2026/Q3 +1,959,183 5.8%
Tri Locum Partners LP Hedge Fund 2026/Q3 +493,344 0.9%
Bank of America Corporation Public Company 2026/Q3 +427,742 1.0%
J.P. Morgan Asset Management, Inc. Mutual Fund 2026/Q3 +415,426 1.2%
The Goldman Sachs Group, Inc. Public Company 2026/Q3 +395,185 0.9%
Eventide Asset Management, LLC Mutual Fund 2026/Q3 +308,185 11.9%
BlackRock Mutual Fund 2026/Q3 +301,576 6.3%
Trexquant Investment LP Hedge Fund 2026/Q3 +252,834 0.9%
AQR Capital Management Hedge Fund 2026/Q3 +244,910 0.6%
Balyasny Asset Management L.P. Hedge Fund 2026/Q3 +237,767 1.6%
Mariner, LLC Mutual Fund 2026/Q3 +220,359 0.4%
Norges Bank Investment Management Sovereign Wealth Fund 2026/Q3 +194,011 0.4%
Squarepoint OPS LLC Hedge Fund 2026/Q3 +161,098 0.3%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
30 Sep 2026 Mark Hopman Chief Commercial Officer Automatic Disposition -370 $18.96 56,109
21 Sep 2026 Christina Jones Independent Director Automatic Disposition -6,430 $23.00 4,842
15 Sep 2026 Mark Hopman Chief Commercial Officer Automatic Disposition -30,779 $20.13 56,479
15 Sep 2026 Mike Mensinger Chief Product Officer Automatic Disposition -2,650 $22.00 177,390
13 Sep 2026 Mark Hopman Chief Commercial Officer Automatic Disposition -775 $15.52 86,382
8 Sep 2026 Mark Hopman Chief Commercial Officer Open Market Disposition -35,994 $18.46 88,033
2 Sep 2026 Sean Saint Chief Executive Officer Automatic Disposition -5,641 $20.08 398,429
1 Sep 2026 Sean Saint Chief Executive Officer Open Market Disposition -16,867 $19.11 404,070
1 Sep 2026 Stephen Feider Chief Financial Officer Open Market Disposition -6,675 $19.11 159,378
1 Sep 2026 Steven Russell Chief Medical Officer Open Market Disposition -4,221 $19.11 169,628
1 Sep 2026 Mark Hopman Chief Commercial Officer Open Market Disposition -5,327 $19.11 124,027
1 Sep 2026 Mike Mensinger Chief Product Officer Open Market Disposition -4,375 $19.11 180,040
28 Jun 2026 Stephen Feider Chief Financial Officer Derivative Exercise and Sale -10,000 $17.05 166,053
23 Jun 2026 Christina Jones Independent Director Automatic Disposition -1,406 $15.00 5,032
23 Jun 2026 Mark Hopman Chief Commercial Officer Automatic Disposition -1,258 $15.01 129,354
3 Jun 2026 Christina Jones Independent Director Automatic Disposition -2,811 $14.00 6,438
3 Jun 2026 Mark Hopman Chief Commercial Officer Automatic Disposition -275 $12.31 130,612
1 Jun 2026 Sean Saint Chief Executive Officer Open Market Disposition -16,872 $12.61 420,937
1 Jun 2026 Stephen Feider Chief Financial Officer Open Market Disposition -6,676 $12.61 166,053
1 Jun 2026 Steven Russell Chief Medical Officer Open Market Disposition -4,222 $12.61 173,849

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 10,617,768 23.6% 9.9
31 Aug 2026 9,400,691 20.9% 9.0
14 Aug 2026 7,494,706 16.7% 5.5
31 Jul 2026 7,604,900 16.9% 6.0
15 Jul 2026 6,609,679 14.8% 7.0
30 Jun 2026 6,819,825 15.3% 5.9

Discussion

No comments yet — be the first to weigh in on BBNX.

Leave a comment

Scroll to Top